Takeda Pharmaceutical Company Limited (4502.T)
JPY 4093.0
(-0.1%)
JPY 4093.0
(-0.1%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 640.32 Billion | 977.15 Billion | 1123.1 Billion | 1010.93 Billion | 669.75 Billion | 328.47 Billion |
| Net Income | 144.06 Billion | 317.03 Billion | 230.16 Billion | 376.17 Billion | 44.29 Billion | 109.01 Billion |
| Depreciation & Amortization | 728 Billion | 664.4 Billion | 583.15 Billion | 559.67 Billion | 583.64 Billion | 272.44 Billion |
| Deferred income taxes | -91.4 Billion | 58.05 Billion | 72.4 Billion | -9.93 Billion | -105.04 Billion | -14.11 Billion |
| Stock-based compensation | 70.87 Billion | 60.67 Billion | 43.37 Billion | 37.66 Billion | 29.12 Billion | 20.08 Billion |
| Change in working capital | -263.55 Billion | -25.26 Billion | 98.6 Billion | 275.78 Billion | 94.67 Billion | 75.94 Billion |
| Other non-cash items | 1598.34 Billion | -97.74 Billion | 95.4 Billion | -228.41 Billion | 23.06 Billion | -134.89 Billion |
| Investing Cash Flow | -488.21 Billion | -607.1 Billion | -198.12 Billion | 393.53 Billion | 292.11 Billion | -2835.69 Billion |
| Investments in PPE | -480.73 Billion | -633.68 Billion | -186.03 Billion | -236.46 Billion | -217.71 Billion | -134.11 Billion |
| Acquisitions | -4.73 Billion | 7.95 Billion | -21.47 Billion | 530.38 Billion | 456.65 Billion | -2873.55 Billion |
| Investment purchases | -6.76 Billion | -10.15 Billion | -8.34 Billion | -12.59 Billion | -7.55 Billion | -17.09 Billion |
| Sales/Maturities of investments | 8.02 Billion | 22.25 Billion | 16.92 Billion | 74.6 Billion | 49.4 Billion | 65.03 Billion |
| Other Investing Activities | -4 Billion | 6.52 Billion | 808 Million | 37.6 Billion | 11.32 Billion | 124.03 Billion |
| Financing Cash Flow | -254.04 Billion | -709.14 Billion | -1070.26 Billion | -1088.35 Billion | -1005.21 Billion | 2946.23 Billion |
| Debt repayment | -116.16 Billion | -400.07 Billion | -849.81 Billion | -1840.01 Billion | -234.86 Billion | -1.74 Billion |
| Dividends payments | -287.18 Billion | -279.41 Billion | -283.66 Billion | -283.35 Billion | -282.58 Billion | -142.95 Billion |
| Common Stock Repurchased | -2.32 Billion | -26.92 Billion | -77.53 Billion | -2.14 Billion | -3.73 Billion | -1.17 Billion |
| Common Stock Issuance | - | 6.44 Billion | 141.12 Billion | 1072.16 Billion | - | 3128.33 Billion |
| Other Financing Activities | -26.1 Billion | -9.17 Billion | -385 Million | -35 Billion | -484.02 Billion | -36.22 Billion |
| Accounts receivables | 15.1 Billion | 75.12 Billion | 127.29 Billion | -9.31 Billion | -34.82 Billion | -13.38 Billion |
| Accounts payables | -9.89 Billion | -53.13 Billion | 75.54 Billion | 210.02 Billion | -29.93 Billion | -16.41 Billion |
| Inventory | -115.74 Billion | -79.15 Billion | -46.14 Billion | 25.97 Billion | 137.49 Billion | 58.67 Billion |
| Other working capital | -153.02 Billion | 31.89 Billion | -58.09 Billion | 49.09 Billion | 21.93 Billion | 47.06 Billion |
| Cash at beginning of period | 229.55 Billion | 849.69 Billion | 966.22 Billion | 637.61 Billion | 702.72 Billion | 294.97 Billion |
| Cash at end of period | 457.8 Billion | 533.53 Billion | 849.69 Billion | 966.22 Billion | 637.61 Billion | 702.09 Billion |
| Capital Expenditure | -480.73 Billion | -633.68 Billion | -186.03 Billion | -236.46 Billion | -217.71 Billion | -134.11 Billion |
| Effect of forex changes on cash | 26.2 Billion | 22.92 Billion | 28.75 Billion | 12.5 Billion | -21.76 Billion | -31.26 Billion |
| Net cash flow / Change in cash | 228.24 Billion | -316.16 Billion | -116.52 Billion | 328.6 Billion | -65.1 Billion | 407.12 Billion |
| Free Cash Flow | 159.59 Billion | 343.46 Billion | 937.06 Billion | 774.46 Billion | 452.04 Billion | 194.36 Billion |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 92.04 Billion | 95.24 Billion | -3.01 Billion | 144.06 Billion | 105.75 Billion | -47.97 Billion |
| Depreciation & Amortization | 192.45 Billion | 192.22 Billion | 186.74 Billion | 728 Billion | 187.06 Billion | 182.69 Billion |
| Deferred income taxes | - | 41.3 Billion | -44.52 Billion | -91.4 Billion | -44.49 Billion | -48 Billion |
| Stock-based compensation | - | 15.38 Billion | 18.18 Billion | 70.87 Billion | 18.7 Billion | 18.53 Billion |
| Change in working capital | -80.45 Billion | -189.97 Billion | 99.06 Billion | -263.55 Billion | -166.02 Billion | 1.59 Billion |
| Other non-cash items | 54.95 Billion | 541.6 Billion | 307.01 Billion | 1598.34 Billion | 45.44 Billion | 92.06 Billion |
| Investing Cash Flow | -79.99 Billion | -161.23 Billion | -77.06 Billion | -488.21 Billion | -75.26 Billion | -60.57 Billion |
| Investments in PPE | -49.47 Billion | -137.79 Billion | -64.32 Billion | -480.73 Billion | -77.12 Billion | -70.04 Billion |
| Acquisitions | 5.41 Billion | 2.95 Billion | -13.7 Billion | -4.73 Billion | -26.25 Billion | -7 Million |
| Investment purchases | -14.75 Billion | -12.98 Billion | -2.04 Billion | -6.76 Billion | -2.46 Billion | -1.59 Billion |
| Sales/Maturities of investments | 17.79 Billion | 5.31 Billion | 6.93 Billion | 8.02 Billion | 458 Million | 88 Million |
| Other Investing Activities | -27.79 Billion | -18.72 Billion | -3.92 Billion | -4 Billion | 30.1 Billion | 10.97 Billion |
| Financing Cash Flow | -83.21 Billion | 331.84 Billion | -36.53 Billion | -254.04 Billion | -97.76 Billion | -140.65 Billion |
| Debt repayment | -57.08 Billion | -440.52 Billion | -56.97 Billion | -116.16 Billion | -96.5 Billion | -157.07 Billion |
| Dividends payments | -9.19 Billion | -138.11 Billion | -9.12 Billion | -287.18 Billion | -138.25 Billion | -9.06 Billion |
| Common Stock Repurchased | - | -1.88 Billion | - | -2.32 Billion | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -16.92 Billion | 42.22 Billion | -73.19 Billion | -26.1 Billion | 136.99 Billion | 25.48 Billion |
| Accounts receivables | -10.03 Billion | -47.74 Billion | 73.89 Billion | 15.1 Billion | 14.28 Billion | 17.29 Billion |
| Accounts payables | 376 Million | -37.45 Billion | -30.48 Billion | -9.89 Billion | 70.26 Billion | -15.02 Billion |
| Inventory | -41.13 Billion | -10.07 Billion | 12.74 Billion | -115.74 Billion | -50.55 Billion | -49.34 Billion |
| Other working capital | -29.65 Billion | -94.7 Billion | 42.9 Billion | -153.02 Billion | -200.02 Billion | 48.67 Billion |
| Cash at beginning of period | 804.27 Billion | 205.19 Billion | 288.35 Billion | 229.55 Billion | 318.05 Billion | 316.38 Billion |
| Cash at end of period | 859.01 Billion | 804.27 Billion | 457.8 Billion | 457.8 Billion | 288.35 Billion | 318.05 Billion |
| Capital Expenditure | -49.47 Billion | -137.79 Billion | -64.32 Billion | -480.73 Billion | -77.12 Billion | -70.04 Billion |
| Effect of forex changes on cash | - | 17.22 Billion | 10.56 Billion | 26.2 Billion | -3.11 Billion | 4 Billion |
| Net cash flow / Change in cash | 54.74 Billion | 599.08 Billion | 169.44 Billion | 228.24 Billion | -29.69 Billion | 1.67 Billion |
| Free Cash Flow | 209.52 Billion | 21.57 Billion | 208.14 Billion | 159.59 Billion | 69.32 Billion | 128.86 Billion |
2489
FANG
4249
CMPVF
1725
6370